Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Repair Control EGF** is a topical EASYDEW EX skin-care product developed by DN Company and manufactured by Cosmax. Its labeled active ingredient is nepidermin, a recombinant human epidermal growth factor, at 0.001% concentration. Nepidermin is intended to activate epidermal growth factor receptor signaling in the skin, supporting epidermal-cell proliferation and repair. The product is supplied as a targeted external-use liquid treatment with an anti-wrinkle purpose; its formula also includes skin-conditioning and moisturizing excipients such as caffeine, ceramide NP, sodium hyaluronate, argan oil, and macadamia seed oil. The United States product label is categorized as an unapproved human OTC drug label rather than an FDA-approved therapeutic product. ([fda.report](https://fda.report/DailyMed/ac1dc30b-75a8-4955-8aea-8727ee6d7a3c))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Repair Control EGF.